MedAvante Presents New Research at Alzheimer’s Association International Conference (AAIC)

The Clinical Dementia Rating scale (CDR) is widely being used as sole primary, and co-primary, endpoint in therapeutic clinical trials of Alzheimer’s disease (AD). The CDR, however, is challenging to score, and scoring errors are common. An eSource platform with multi-level clinical guidance for CDR administration can reduce scoring errors that contribute to poor interrater reliability, thereby improving signal detection.

eSource administration of the CDR: Preliminary validation of internal consistency checks

Download Poster